Tags : copper Cu 64 dotatate injection

RadioMedix and Curium Detectnet (copper Cu 64 dotatate injection) Receives

Shots: The approval is based on P-lll study which involves assessing Detectnet (copper Cu 64 dotatate injection) in Neuroendocrine Tumors (NETs) patients. Curium expects to launch detectnet immediately with doses available through various nuclear pharmacies The P-III results demonstrated that the clinical sensitivity and specificity provide great aid to clinicians to develop an accurate treatment […]Read More